191 related articles for article (PubMed ID: 21402562)
1. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
Inaba Y; Ozawa R; Imagawa T; Mori M; Hara Y; Miyamae T; Aoki C; Saito T; Yokota S
Ann Rheum Dis; 2011 Sep; 70(9):1693-5. PubMed ID: 21402562
[No Abstract] [Full Text] [Related]
2. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
Inaba Y; Ozawa R; Aoki C; Imagawa T; Mori M; Hara R; Miyamae T; Saito T; Yokota S
Mod Rheumatol; 2013 Jul; 23(4):667-73. PubMed ID: 22791270
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
Aoki C; Inaba Y; Choe H; Kaneko U; Hara R; Miyamae T; Imagawa T; Mori M; Oba MS; Yokota S; Saito T
J Rheumatol; 2014 Jun; 41(6):1171-7. PubMed ID: 24786929
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children.
Billiau AD; Cornillie F; Wouters C
J Rheumatol; 2002 May; 29(5):1111-4. PubMed ID: 12022340
[No Abstract] [Full Text] [Related]
5. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
Woo P; Wilkinson N; Prieur AM; Southwood T; Leone V; Livermore P; Wythe H; Thomson D; Kishimoto T
Arthritis Res Ther; 2005; 7(6):R1281-8. PubMed ID: 16277681
[TBL] [Abstract][Full Text] [Related]
6. Safety of tocilizumab in the treatment of juvenile idiopathic arthritis.
Machado SH; Xavier RM
Expert Opin Drug Saf; 2017 Apr; 16(4):493-500. PubMed ID: 28277841
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
Ann Rheum Dis; 2013 Apr; 72(4):627-8. PubMed ID: 23204515
[No Abstract] [Full Text] [Related]
8. Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.
Pacharapakornpong T; Vallibhakara SA; Lerkvaleekul B; Vilaiyuk S
Rheumatol Int; 2017 Feb; 37(2):251-255. PubMed ID: 27798725
[TBL] [Abstract][Full Text] [Related]
9. The time has come to include assessment of radiographic progression in juvenile idiopathic arthritis clinical trials.
Ravelli A
J Rheumatol; 2008 Apr; 35(4):553-7. PubMed ID: 18398949
[No Abstract] [Full Text] [Related]
10. Atlanto-axial subluxation in a patient with polyarticular juvenile idiopathic arthritis: clinical and radiological response to infliximab.
Cannioto Z; Taddio A; Lepore L; Zennaro F
Clin Exp Rheumatol; 2008; 26(4):704-5. PubMed ID: 18799110
[No Abstract] [Full Text] [Related]
11. Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.
Malattia C; Ruperto N; Pederzoli S; Palmisani E; Pistorio A; Wouters C; Dolezalova P; Flato B; Garay S; Giancane G; Wells C; Douglass W; Brunner HI; De Benedetti F; Ravelli A;
Arthritis Res Ther; 2020 Sep; 22(1):211. PubMed ID: 32912276
[TBL] [Abstract][Full Text] [Related]
12. Biologicals in Juvenile Idiopathic Arthritis.
Saini I; Dawman L; Gupta N; Kabra SK
Indian Pediatr; 2016 Mar; 53(3):260-1. PubMed ID: 27029697
[TBL] [Abstract][Full Text] [Related]
13. [Abbott proposes in Europe and the U.S.A. the approval of Humira (adalimumab) for therapy of juvenile idiopathic arthritis. Pediatric clinical trial shows very promising results in juvenile rheumatoid arthritis].
Shandwick W; Bude S
Kinderkrankenschwester; 2007 Aug; 26(8):335-6. PubMed ID: 17844688
[No Abstract] [Full Text] [Related]
14. Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
Tappeiner C; Heinz C; Ganser G; Heiligenhaus A
J Rheumatol; 2012 Jun; 39(6):1294-5. PubMed ID: 22661419
[No Abstract] [Full Text] [Related]
15. Guidance on using tocilizumab for juvenile idiopathic arthritis.
Yokota S; Imagawa T; Takei S; Murata T; Tomiita M; Itoh Y; Fujikawa S; Mori M
Mod Rheumatol; 2011 Dec; 21(6):563-71. PubMed ID: 21597951
[TBL] [Abstract][Full Text] [Related]
16. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
[TBL] [Abstract][Full Text] [Related]
17. [Biologic response modifiers for juvenile idiopathic arthritis].
Yokota S
Nihon Rinsho; 2007 Jul; 65(7):1331-5. PubMed ID: 17642252
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
Yokota S; Imagawa T; Mori M; Miyamae T; Aihara Y; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
Lancet; 2008 Mar; 371(9617):998-1006. PubMed ID: 18358927
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
Quesada-Masachs E; Caballero CM
J Rheumatol; 2017 Feb; 44(2):260-261. PubMed ID: 28148759
[No Abstract] [Full Text] [Related]
20. Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
Miyamae T; Yokoya S; Yamanaka H; Yokota S
Mod Rheumatol; 2014 Jul; 24(4):567-71. PubMed ID: 24252004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
